Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This systematic review and meta-analysis found limited, low-quality evidence suggesting that platelet-rich plasma injections may increase hair density in patients with androgenetic alopecia compared to saline, but results were inconclusive for alopecia areata.

This study found that Traditional Chinese Medicine increased hair follicle numbers and improved hair growth metrics in androgenetic alopecia rodent models, suggesting potential benefits linked to reduced serum testosterone levels.

This study found that women with PCOS have a significant risk of mental health disorders, including depression and anxiety, but results varied due to methodological differences, and ethnic disparities were not well-examined.

This letter references a previous systematic review and meta-analysis on how nocturia may impact mortality but does not present new findings itself.

In this systematic review and meta-analysis, researchers found that methotrexate and leflunomide have similar efficacy for rheumatoid arthritis as first-line treatments, but methotrexate offered a greater reduction in swollen joints, while leflunomide was more associated with liver enzyme increases and fewer gastrointestinal side effects.

This study found that women with central centrifugal cicatricial alopecia had a substantial prevalence of systemic comorbidities, including strong associations with dyslipidemia, uterine leiomyomas, and anxiety disorders.

This review of non-surgical treatments for androgenetic alopecia reports that combination therapies, particularly platelet-rich plasma with low-level laser therapy, tend to be more effective than using each treatment alone.

In this network meta-analysis, the researchers reported that topical minoxidil 5% was the most effective off-label therapy for increasing hair density in men with androgenetic alopecia, while other treatments like melatonin and cetirizine showed potential benefits, highlighting a need for further comparative trials.

This study found a significant association between baldness patterns, particularly vertex and early-onset baldness, and an increased risk of prostate cancer.

This network meta-analysis found that for female pattern hair loss, microneedling combined with minoxidil ranked highest for hair density and patient satisfaction, while poly-L-lactic acid threads plus minoxidil led in hair diameter; however, the evidence is uncertain and lacks placebo-controlled trials.

This study found that individuals with frontal fibrosing alopecia have increased odds of thyroid disease, lupus erythematous, vitiligo, and heart disease, supporting the consideration of FFA as a systemic disorder.

This study found that oral JAK inhibitors significantly improve hair regrowth in adults with moderate-to-severe alopecia areata compared to placebo, although they are associated with a higher risk of non-serious adverse events.

This study determined that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, especially when combined with other agents like minoxidil, PRP, or growth factors.

This study found that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, with the greatest improvements in hair density and thickness seen in combination therapies.

This study reports that low-level light therapy and fractional lasers are effective and safe treatments for androgenetic alopecia, with more pronounced results when combined with other therapies.

This study found that autologous growth factor injections for androgenetic alopecia improved hair density, thickness, and patient satisfaction over 12 months; however, high bias risk and non-standardized methods limit the evidence's reliability, highlighting the need for larger, standardized trials.

In this study, alopecia areata was associated with a statistically significant reduction in melanoma incidence, but not in overall skin cancer risk, highlighting the need for cautious interpretation due to heterogeneity.

This study suggests that autologous micrograft technology may be more effective than finasteride in promoting hair growth in patients with androgenetic alopecia.

This source reports that in adults with non-scarring alopecia, polyphenolic interventions significantly improved hair density and total area hair count compared to controls, although considerable variability was present in results, highlighting the need for further research.

This systematic review and meta-analysis found that polyphenolic interventions significantly improved hair density and total area hair count in adults with non-scarring alopecia, but substantial heterogeneity was observed.

This study evaluated the efficacy of polyphenolic compounds for hair growth in adults with non-scarring alopecia and found that these interventions significantly improved hair density and total area hair count compared to controls, although results were not significantly different from minoxidil.

Topical hair loss treatments have a stronger placebo effect than systemic ones.

Topical treatments for hair loss have a stronger placebo effect than systemic ones.

Placebo treatments can significantly affect perceived hair growth in androgenetic alopecia.

Placebo treatments can significantly affect perceived hair growth in androgenetic alopecia.

Placebo treatments can improve hair growth and satisfaction in hair loss.

Placebo treatments can improve hair growth and satisfaction in hair loss.

This review presents evidence supporting acupuncture's potential benefits for AA treatment but notes the findings are limited by low-quality evidence and small sample sizes, suggesting a need for future large-scale, rigorous studies.

This study reviewed multiple research articles and found that patients with telogen effluvium, primarily women, had significantly lower levels of serum ferritin and vitamin D compared to healthy controls, suggesting a role for trace element imbalances in hair loss.

This systematic review and meta-analysis found that patients with telogen effluvium, primarily females, exhibited significantly lower serum levels of ferritin and vitamin D compared to healthy controls, suggesting trace element imbalances play a crucial role in this type of hair loss.